Skip to Main Content

Paper Details

HES5 silencing is an early and recurrent change in prostate tumourigenesis.
Endocr Relat Cancer
10
2015
Author NameAffiliation
Charlie E MassieCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital
Helen J RossCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital
Hayley J LuxtonCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital
Jonathan KayCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital
Hayley C WhitakerCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital
Mark J DunningCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital
Alastair D LambCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital, UK Cancer Research UK Cambridge InstituteUniversity of Cambridge
Daniel S BrewerCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital
Colin S CooperCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital, UK Cancer Research UK Cambridge InstituteUniversity of Cambridge
Rosalind A EelesCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital, UK Cancer Research UK Cambridge InstituteUniversity of Cambridge
Anne Y WarrenCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital
Simon Tavar??Cancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital
David E NealCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital, UK Cancer Research UK Cambridge InstituteUniversity of Cambridge
Andy G LynchCancer Research UK Cambridge InstituteUniversity of Cambridge, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital
  • 1 - 14

Datasets